Literature DB >> 18426839

Screening for and prevention of type 2 diabetes.

Elizabeth C Goyder.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18426839      PMCID： PMC2394585          DOI： 10.1136/bmj.39553.480706.80

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

Review 1.  The runaway weight gain train: too many accelerators, not enough brakes.

Authors:  Boyd Swinburn; Garry Egger
Journal:  BMJ       Date:  2004-09-25

2.  A rational framework for decision making by the National Institute For Clinical Excellence (NICE).

Authors:  Karl Claxton; Mark Sculpher; Michael Drummond
Journal:  Lancet       Date:  2002-08-31       Impact factor: 79.321

Review 3.  Waking up from the DREAM of preventing diabetes with drugs.

Authors:  Victor M Montori; William L Isley; Gordon H Guyatt
Journal:  BMJ       Date:  2007-04-28

4.  Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.

Authors:  David M Eddy; Leonard Schlessinger; Richard Kahn
Journal:  Ann Intern Med       Date:  2005-08-16       Impact factor: 25.391

5.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

6.  Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis.

Authors:  Clare L Gillies; Paul C Lambert; Keith R Abrams; Alex J Sutton; Nicola J Cooper; Ron T Hsu; Melanie J Davies; Kamlesh Khunti
Journal:  BMJ       Date:  2008-04-21

Review 7.  Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis.

Authors:  Clare L Gillies; Keith R Abrams; Paul C Lambert; Nicola J Cooper; Alex J Sutton; Ron T Hsu; Kamlesh Khunti
Journal:  BMJ       Date:  2007-01-19

8.  What determines the cost-effectiveness of diabetes screening?

Authors:  C Glümer; M Yuyun; S Griffin; D Farewell; D Spiegelhalter; A L Kinmonth; N J Wareham
Journal:  Diabetologia       Date:  2006-04-26       Impact factor: 10.122
  8 in total
  6 in total

1.  Genomics into Healthcare: the 5th Pan Arab Human Genetics Conference and 2013 Golden Helix Symposium.

Authors:  Paolo Fortina; Najib Al Khaja; Mahmoud Taleb Al Ali; Abdul Rezzak Hamzeh; Pratibha Nair; Federico Innocenti; George P Patrinos; Larry J Kricka
Journal:  Hum Mutat       Date:  2014-03-31       Impact factor: 4.878

2.  Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): randomised trial.

Authors:  Theresa M Marteau; Eleanor Mann; A Toby Prevost; Joana C Vasconcelos; Ian Kellar; Simon Sanderson; Michael Parker; Simon Griffin; Stephen Sutton; Ann Louise Kinmonth
Journal:  BMJ       Date:  2010-05-13

3.  Implementation salvage experiences from the Melbourne diabetes prevention study.

Authors:  James Dunbar; Andrea Hernan; Edward Janus; Nathalie Davis-Lameloise; Dino Asproloupos; Sharleen O'Reilly; Amy Timoshanko; Elizabeth Stewart; Catherine M Bennett; Greg Johnson; Rob Carter
Journal:  BMC Public Health       Date:  2012-09-19       Impact factor: 3.295

4.  Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): trial protocol.

Authors:  Eleanor Mann; A Toby Prevost; Simon Griffin; Ian Kellar; Stephen Sutton; Michael Parker; Simon Sanderson; Ann Louise Kinmonth; Theresa M Marteau
Journal:  BMC Public Health       Date:  2009-02-20       Impact factor: 3.295

5.  Are people with negative diabetes screening tests falsely reassured? Parallel group cohort study embedded in the ADDITION (Cambridge) randomised controlled trial.

Authors:  Charlotte A M Paddison; Helen C Eborall; Stephen Sutton; David P French; Joana Vasconcelos; A Toby Prevost; Ann-Louise Kinmonth; Simon J Griffin
Journal:  BMJ       Date:  2009-11-30

6.  Motivational interviewing and problem solving treatment to reduce type 2 diabetes and cardiovascular disease risk in real life: a randomized controlled trial.

Authors:  Jeroen Lakerveld; Sandra D Bot; Mai J Chinapaw; Maurits W van Tulder; Piet J Kostense; Jacqueline M Dekker; Giel Nijpels
Journal:  Int J Behav Nutr Phys Act       Date:  2013-04-19       Impact factor: 6.457
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.